you are here:

Ranbaxy Laboratories Ltd.

BSE: 500359 | NSE: RANBAXY | Series: NA | ISIN: INE015A01028 | SECTOR: Pharmaceuticals

BSE Live

Apr 01, 16:00
859.90 0.00 (0.00%)
Volume
No Data Available
308,222
  • Prev. Close

    859.90

  • Open Price

    814.90

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Ranbaxy Laboratories is not traded on BSE in the last 30 days

NSE Live

Apr 01, 15:59
859.80 0.00 (0.00%)
Volume
No Data Available
5,415,702
  • Prev. Close

    859.80

  • Open Price

    814.70

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    859.80 (9924)

Ranbaxy Laboratories is not traded on NSE in the last 30 days

Financials

2020 2019 2018 2017 2016
Half Yearly Results of Ranbaxy Laboratories (in Rs. Cr.) Sep '14 Dec '13 Jun '13 Dec '12 Jun '12  
Net Sales/Income from operations 3,389.67 2,709.48 2,722.97 2,829.47 3,282.98  
Other Operating Income 97.64 82.92 97.55 81.71 109.39  
Total Income From Operations 3,487.31 2,792.40 2,820.52 2,911.17 3,392.37  
EXPENDITURE  
Consumption of Raw Materials 616.67 860.24 810.22 785.61 751.16  
Purchase of Traded Goods 411.27 403.59 354.28 399.71 409.30  
Increase/Decrease in Stocks 203.91 -153.36 -25.06 -41.94 -7.31  
Power & Fuel -- -- -- -- --  
Employees Cost 534.41 539.58 508.88 514.79 504.80  
Depreciation 125.80 140.25 89.94 90.75 95.41  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 950.33 1,310.26 1,291.11 1,109.42 1,417.53  
P/L Before Other 644.92 -308.17 -208.84 52.83 221.50  
Other Income 45.78 64.95 83.37 124.82 114.78  
P/L Before Int. 690.70 -243.22 -125.47 177.65 336.27  
Interest 278.74 229.47 206.73 116.91 180.07  
P/L Before Exceptional Items & Tax 411.97 -472.70 -332.20 60.74 156.20  
Exceptional Items -15.86 -765.50 -206.46 -126.59 -254.64  
P/L Before Tax 396.10 -1,238.19 -538.66 -65.85 -98.44  
Tax 9.24 -- -- -1.94 --  
P/L After Tax from Ordinary Activities 386.87 -1,238.19 -538.66 -63.90 -98.44  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 386.87 -1,238.19 -538.66 -63.90 -98.44  
Equity Share Capital 211.95 211.55 211.55 211.46 211.06  
Reserves Excluding Revaluation Reserves -- -- -- 1,709.51 --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 9.13 -- -12.74 -- -2.33  
Diluted EPS 9.11 -- -12.74 -- -2.33  
EPS After Extra Ordinary  
Basic EPS. 9.13 -- -12.74 -- -2.33  
Diluted EPS. 9.11 -- -12.74 -- -2.33  
Public Share Holding  
No Of Shares (Crores) 14.93 14.80 14.57 14.52 14.50  
Share Holding (%) 35.22 34.93 34.43 34.34 34.35  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). 26.87 26.87 26.87 26.87 26.87  
- Per. of shares (as a % of the total sh. of prom. and promoter group). 100.00 100.00 100.00 100.00 100.00  
- Per. of shares (as a % of the total Share Cap. of the company). 63.37 63.41 63.51 63.54 63.66  
Source : Dion Global Solutions Limited